-
medical use in the
European Union in
November 2023. Trastuzumab-strf (
Hercessi) was
approved for
medical use in the
United States in
April 2024. In July...
- trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp, trastuzumab-strf, Adheroza,
Hercessi, Herzuma, Herwenda, Kanjinti, Ogivri, Ontruzant, Trastucip, Trazimera,...
-
heptolamide (INN)
Hepzato hepzidine (INN)
Herceptin Herceptin Hylecta Hercessi heroin Herplex Herwenda Herzuma hetacillin (INN)
hetaflur (INN) heteronium...
- ustekinumab-aekn/Selarsdi ustekinumab/Stelara
April 2024 trastuzumab-strf/
Hercessi trastuzumab/Herceptin May 2024 aflibercept-yszy/Opuviz aflibercept/Eylea...
